In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation method.

Autor: Yu, S S1, Nukaya, I1, Enoki, T2, Chatani, E1, Kato, A2, Goto, Y1, Dan, K1, Sasaki, M1, Tomita, K2, Tanabe, M2, Chono, H1, Mineno, J1, Kato, I2
Zdroj: Cancer Gene Therapy. Aug2008, Vol. 15 Issue 8, p508-516. 9p. 3 Charts, 3 Graphs.
Databáze: Academic Search Ultimate